Actualités Virologic (MM) - VLGC | Actions NASDAQ

Monogram Biosciences to Present at Thomas Weisel Partners Healthcare Conference 2005 on September 9, 2005

SOUTH SAN FRANCISCO, Calif., Sept. 7 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (NASDAQ:MGRM), formerly ViroLogic, Inc., announced...

ViroLogic Changes Its Name to Monogram Biosciences

Conference Call Scheduled for 4:30 p.m. Eastern Today SO. SAN FRANCISCO, Calif., Sept. 6 /PRNewswire-FirstCall/ -- ViroLogic, Inc...

ViroLogic Appoints William J. Welch Senior Vice President and Chief Commercial Officer

SOUTH SAN FRANCISCO, Calif., Sept. 1 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (NASDAQ:VLGC) today announced the appointment of William J. Welch...

ViroLogic Announces Second Quarter 2005 Financial Results Conference Call

ViroLogic Announces Second Quarter 2005 Financial Results Conference Call SOUTH SAN FRANCISCO, Calif., July 19 /PRNewswire-FirstCall/...

ViroLogic Announces Second Quarter 2005 Financial Results

ViroLogic Announces Second Quarter 2005 Financial Results - HIV clinical trials provide boost to testing revenues - 35% revenue growth - SOUTH SAN...

ViroLogic Announces Second Quarter 2005 Financial Results Conference Call

ViroLogic Announces Second Quarter 2005 Financial Results Conference Call SOUTH SAN FRANCISCO, Calif., July 19 /PRNewswire-FirstCall/...

ViroLogic Announces Multi-Year Service Agreement With Schering-Plough to Support New HIV Drug Discovery and Development Efforts

ViroLogic Announces Multi-Year Service Agreement With Schering-Plough to Support New HIV Drug Discovery and Development Efforts SOUTH SAN...

ViroLogic to Present at Pacific Growth Equities 2005 Life Sciences Growth Conference

ViroLogic to Present at Pacific Growth Equities 2005 Life Sciences Growth Conference SO. SAN FRANCISCO, Calif., May 31 /PRNewswire-FirstCall/...

ViroLogic Added to the NASDAQ Biotechnology Index

ViroLogic Added to the NASDAQ Biotechnology Index SOUTH SAN FRANCISCO, Calif., May 20 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (NASDAQ:VLGC...

ViroLogic's eTag System Demonstrates Potential Ability to Better Select Breast Cancer Patients for Therapy With Herceptin

ViroLogic's eTag System Demonstrates Potential Ability to Better Select Breast Cancer Patients for Therapy With Herceptin -Abstract #553...

Study Demonstrates ViroLogic's eTag System Can Measure Activated VEGF Receptor, Target for Anti-Angiogenic Treatments

Study Demonstrates ViroLogic's eTag System Can Measure Activated VEGF Receptor, Target for Anti-Angiogenic Treatments -Abstract #9595- ORLANDO...

Semi-Annual Changes to the NASDAQ Biotechnology Index

Semi-Annual Changes to the NASDAQ Biotechnology Index NEW YORK, May 13 /PRNewswire-FirstCall/ -- The Nasdaq Stock Market, Inc. ("NASDAQ...

ViroLogic Announces Presentations on Its eTag Technology at the 2005 American Society of Clinical Oncology Annual Meeting (ASCO)

ViroLogic Announces Presentations on Its eTag Technology at the 2005 American Society of Clinical Oncology Annual Meeting (ASCO) SOUTH SAN...

ViroLogic Announces First Quarter 2005 Financial Results Conference Call

ViroLogic Announces First Quarter 2005 Financial Results Conference Call SOUTH SAN FRANCISCO, Calif., April 26 /PRNewswire-FirstCall/...

ViroLogic Announces First Quarter 2005 Financial Results

ViroLogic Announces First Quarter 2005 Financial Results - Progress with oncology clinical studies and HIV pharmaceutical testing SOUTH SAN...

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Virologic (MM) (VLGC)

Votre Hub pour des idées et discussions en direct en temps réel

VLGC Actualités

Monogram Biosciences to Present at Thomas Weisel Partners Healthcare Conference 2005 on September 9, 2005

ViroLogic Changes Its Name to Monogram Biosciences

ViroLogic Appoints William J. Welch Senior Vice President and Chief Commercial Officer

ViroLogic Announces Second Quarter 2005 Financial Results Conference Call

ViroLogic Announces Second Quarter 2005 Financial Results

ViroLogic Announces Second Quarter 2005 Financial Results Conference Call

ViroLogic Announces Multi-Year Service Agreement With Schering-Plough to Support New HIV Drug Discovery and Development Efforts

ViroLogic to Present at Pacific Growth Equities 2005 Life Sciences Growth Conference

ViroLogic Added to the NASDAQ Biotechnology Index

ViroLogic's eTag System Demonstrates Potential Ability to Better Select Breast Cancer Patients for Therapy With Herceptin

Study Demonstrates ViroLogic's eTag System Can Measure Activated VEGF Receptor, Target for Anti-Angiogenic Treatments

Semi-Annual Changes to the NASDAQ Biotechnology Index

ViroLogic Announces Presentations on Its eTag Technology at the 2005 American Society of Clinical Oncology Annual Meeting (ASCO)

ViroLogic Announces First Quarter 2005 Financial Results Conference Call

ViroLogic Announces First Quarter 2005 Financial Results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Virologic (MM) (VLGC) Actualités

Virologic (MM) (VLGC)

Votre Hub pour des idées et discussions en direct en temps réel

VLGC Actualités

Monogram Biosciences to Present at Thomas Weisel Partners Healthcare Conference 2005 on September 9, 2005

ViroLogic Changes Its Name to Monogram Biosciences

ViroLogic Appoints William J. Welch Senior Vice President and Chief Commercial Officer

ViroLogic Announces Second Quarter 2005 Financial Results Conference Call

ViroLogic Announces Second Quarter 2005 Financial Results

ViroLogic Announces Second Quarter 2005 Financial Results Conference Call

ViroLogic Announces Multi-Year Service Agreement With Schering-Plough to Support New HIV Drug Discovery and Development Efforts

ViroLogic to Present at Pacific Growth Equities 2005 Life Sciences Growth Conference

ViroLogic Added to the NASDAQ Biotechnology Index

ViroLogic's eTag System Demonstrates Potential Ability to Better Select Breast Cancer Patients for Therapy With Herceptin

Study Demonstrates ViroLogic's eTag System Can Measure Activated VEGF Receptor, Target for Anti-Angiogenic Treatments

Semi-Annual Changes to the NASDAQ Biotechnology Index

ViroLogic Announces Presentations on Its eTag Technology at the 2005 American Society of Clinical Oncology Annual Meeting (ASCO)

ViroLogic Announces First Quarter 2005 Financial Results Conference Call

ViroLogic Announces First Quarter 2005 Financial Results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres